|
|
Volumn 7, Issue 8, 2002, Pages 444-445
|
|
Caspase inhibitors for liver disease
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3 [2 [(2 TERT BUTYLPHENYLAMINOOXALYL)AMINO]PROPIONYLAMINO] 4 OXO 5 (2,3,5,6 TETRAFLUOROPHENOXY)PENTANOIC ACID;
CASPASE 8;
CASPASE INHIBITOR;
CYSTEINE;
UNCLASSIFIED DRUG;
CASPASE;
ENZYME INHIBITOR;
ALCOHOL LIVER DISEASE;
APOPTOSIS;
CLINICAL TRIAL;
DRUG DEVELOPMENT;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
ENZYME INHIBITION;
HUMAN;
LIVER DISEASE;
LIVER INJURY;
SHORT SURVEY;
ARTICLE;
DRUG ANTAGONISM;
DRUG EFFECT;
ENZYMOLOGY;
PHASE 2 CLINICAL TRIAL;
APOPTOSIS;
CASPASES;
CLINICAL TRIALS, PHASE II;
ENZYME INHIBITORS;
HUMAN;
LIVER DISEASES;
HUMANS;
|
|
EID: 0037088990
PISSN: 13596446
EISSN: None
Source Type: Journal
DOI: 10.1016/S1359-6446(02)02256-0 Document Type: Short Survey |
|
Times cited : (3)
|
|
References (2)
|
